Gentrix
Device Recon-Skin And Wound
PDI 00386190001639
General payments
$86,719
Research payments
$6,286
Through program year 2025, $86,719 in general payments and $6,286 in research payments were reported against Gentrix (Recon-Skin And Wound).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $10,412 | 18 |
| 2024 | General | $60,611 | 275 |
| 2024 | Research | $1,736 | 1 |
| 2023 | General | $13,127 | 56 |
| 2023 | Research | $4,550 | 2 |
| 2021 | General | $2,569 | 7 |
Breakdown
The top 5 of 17 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
356 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.